Genetic knockout of TLR2 showed beneficial effects on the two RP models, providing evidence that interfering with the DAMPs pathway could act as a neuroprotective treatment (Sánchez-Cruz et al., 2021). The gene discussed is TLR2; the disease is retinitis pigmentosa 1.